搜尋





搜尋





市場行情
/
股票
/
knsa
/

Kiniksa Pharmaceuticals International PLC

KNSA

添加自選

79.150USD

+15.615+24.58%

收盤 07-28 16:00（美東）報價延遲15分鐘

6.04B總市值

81.35本益比TTM

Kiniksa Pharmaceuticals International PLC

79.150

+15.615+24.58%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

KNSA 利潤表

您可以在這裡找到Kiniksa Pharmaceuticals International PLC的年度或季度收入報告，以深入了解Kiniksa Pharmaceuticals International PLC的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

營業總收入

55.36%243.60M

55.51%214.27M

64.95%202.13M

61.17%180.85M

44.34%156.80M

72.54%137.78M

46.93%122.54M

67.37%112.21M

51.99%108.63M

65.18%79.86M

34.76%83.39M

-32.37%67.05M

164.99%71.47M

50.19%48.34M

230.14%61.88M

719.64%99.14M

250.10%26.97M

--32.19M

--18.75M

--12.10M

--7.70M

----

營業收入

55.36%243.60M

55.51%214.27M

64.95%202.13M

61.17%180.85M

44.34%156.80M

72.54%137.78M

46.93%122.54M

67.37%112.21M

51.99%108.63M

65.18%79.86M

34.76%83.39M

-32.37%67.05M

164.99%71.47M

50.19%48.34M

230.14%61.88M

719.64%99.14M

250.10%26.97M

--32.19M

--18.75M

--12.10M

--7.70M

----

主營業務成本

26.71%23.57M

16.39%20.80M

17.04%20.95M

0.74%20.26M

50.97%18.60M

68.84%17.87M

86.73%17.90M

121.27%20.11M

60.05%12.32M

50.41%10.58M

42.83%9.58M

31.01%9.09M

53.09%7.70M

66.77%7.04M

73.52%6.71M

150.70%6.94M

103.93%5.03M

--4.22M

--3.87M

--2.77M

--2.47M

----

營業費用

58.38%216.41M

48.58%185.00M

28.57%182.36M

28.69%156.83M

25.65%136.64M

29.16%124.51M

70.24%141.84M

56.30%121.87M

45.72%108.75M

61.91%96.40M

49.21%83.31M

47.89%77.97M

61.04%74.63M

7.27%59.54M

1.75%55.84M

23.29%52.72M

-3.98%46.34M

12.63%55.51M

3.74%54.88M

-1.06%42.76M

51.47%48.26M

67.70%49.28M

62.36%52.90M

41.95%43.22M

-18.91%31.86M

-56.56%29.39M

-26.18%32.58M

16.39%30.45M

82.51%39.29M

314.00%67.65M

34.92%44.13M

60.99%26.16M

88.97%21.53M

223.69%16.34M

--32.71M

--16.25M

--11.39M

--5.05M

研發費用

118.09%40.90M

42.17%27.48M

-1.72%34.61M

-7.26%24.17M

-21.92%18.75M

-26.62%19.32M

75.62%35.22M

52.33%26.06M

1.05%24.02M

73.57%26.33M

39.35%20.05M

3.77%17.11M

72.25%23.77M

-27.12%15.17M

-47.54%14.39M

-14.30%16.48M

-42.38%13.80M

-27.42%20.82M

-26.65%27.43M

-38.78%19.24M

7.26%23.95M

37.23%28.68M

63.41%37.40M

42.72%31.42M

-27.63%22.32M

-64.73%20.90M

-36.64%22.89M

6.64%22.01M

79.35%30.85M

369.14%59.25M

20.68%36.12M

47.37%20.64M

85.50%17.20M

301.59%12.63M

--29.93M

--14.01M

--9.27M

--3.15M

折舊攤銷及損耗

----

35.65%468.00K

16.75%467.00K

-3.76%384.00K

-16.74%358.00K

-25.97%345.00K

-25.93%400.00K

-33.83%399.00K

-28.57%430.00K

-21.81%466.00K

-10.30%540.00K

22.31%603.00K

-7.53%602.00K

-9.15%596.00K

-9.88%602.00K

-25.08%493.00K

-9.21%651.00K

110.26%656.00K

17.81%668.00K

1.39%658.00K

20.50%717.00K

-47.47%312.00K

0.18%567.00K

24.09%649.00K

17.13%595.00K

26.11%594.00K

122.83%566.00K

4258.33%523.00K

4133.33%508.00K

5787.50%471.00K

3075.00%254.00K

50.00%12.00K

100.00%12.00K

33.33%8.00K

--8.00K

--6.00K

其他營業費用

68.01%88.07M

72.59%75.58M

45.32%70.03M

116.01%63.31M

74.65%52.42M

110.52%43.79M

184.49%48.19M

69.30%29.31M

114.60%30.01M

150.98%20.80M

125.19%16.94M

274.45%17.31M

280.88%13.99M

0.41%8.29M

800.84%7.52M

--4.62M

--3.67M

--8.25M

--835.00K

----

營業利潤

34.89%27.19M

120.52%29.27M

202.43%19.77M

348.72%24.02M

17330.77%20.16M

180.23%13.27M

-23925.93%-19.30M

11.61%-9.66M

96.29%-117.00K

-47.75%-16.54M

-98.66%81.00K

-123.54%-10.93M

83.72%-3.15M

51.99%-11.20M

116.74%6.05M

251.35%46.41M

52.24%-19.37M

52.68%-23.32M

31.70%-36.13M

29.04%-30.67M

-27.29%-40.55M

-67.70%-49.28M

-62.36%-52.90M

-41.95%-43.22M

18.91%-31.86M

56.56%-29.39M

26.18%-32.58M

-16.39%-30.45M

-82.51%-39.29M

-314.00%-67.65M

-34.92%-44.13M

-60.99%-26.16M

-88.97%-21.53M

-223.69%-16.34M

---32.71M

---16.25M

---11.39M

---5.05M

淨非營業利息收入（費用）

利息收入

45.42%3.95M

48.89%3.41M

50.91%3.50M

27.64%3.14M

12.23%2.72M

1.19%2.29M

-2.07%2.32M

1.19%2.46M

26.42%2.42M

23.69%2.27M

198.36%2.37M

654.04%2.43M

1759.22%1.92M

5288.24%1.83M

931.17%794.00K

6340.00%322.00K

1616.67%103.00K

277.78%34.00K

156.67%77.00K

-89.80%5.00K

-97.74%6.00K

-98.86%9.00K

-97.35%30.00K

-96.46%49.00K

-84.57%266.00K

-56.38%789.00K

-34.57%1.13M

-14.55%1.39M

61.73%1.72M

493.11%1.81M

1198.50%1.73M

859.76%1.62M

596.73%1.07M

312.16%305.00K

--133.00K

--169.00K

--153.00K

--74.00K

稅前利潤

36.14%31.14M

109.96%32.68M

237.05%23.27M

477.13%27.16M

892.93%22.88M

209.03%15.56M

-793.02%-16.98M

15.27%-7.20M

285.96%2.30M

-52.46%-14.28M

-64.19%2.45M

-118.19%-8.50M

93.57%-1.24M

59.79%-9.36M

118.97%6.84M

252.42%46.73M

52.49%-19.27M

52.74%-23.29M

31.80%-36.05M

28.97%-30.66M

-28.34%-40.55M

-72.30%-49.27M

-68.10%-52.87M

-48.55%-43.17M

15.90%-31.59M

56.56%-28.60M

25.84%-31.45M

-18.43%-29.06M

-83.59%-37.56M

-310.59%-65.84M

-30.17%-42.41M

-52.59%-24.54M

-82.05%-20.46M

-222.38%-16.04M

---32.58M

---16.08M

---11.24M

---4.97M

所得稅

65.99%8.37M

43.60%10.09M

212.10%9.07M

58.81%8.72M

-18.79%5.04M

104.96%7.03M

64.49%-8.09M

2.54%5.49M

138.32%6.21M

17.96%3.43M

-1057.44%-22.79M

103.02%5.36M

-2364.11%-16.21M

50.96%2.91M

753.05%2.38M

-150203.39%-177.36M

-29.39%716.00K

816.67%1.93M

-64.64%279.00K

-117.69%-118.00K

-82.74%1.01M

109.64%210.00K

128.03%789.00K

133.32%667.00K

1670.86%5.88M

-12717.65%-2.18M

101.16%346.00K

-1428.24%-2.00M

-85.15%-374.00K

67.92%-17.00K

218.52%172.00K

-156.86%-131.00K

-461.11%-202.00K

-60.61%-53.00K

--54.00K

---51.00K

---36.00K

---33.00K

除稅後利潤

27.70%22.77M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.49%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.63M

---16.03M

---11.20M

---4.94M

持續經營利潤

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.49%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.63M

---16.03M

---11.20M

---4.94M

反常淨利潤

----

---69.00K

----

其他淨損益

--2.66M

----

歸属于母公司的淨利潤

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.21%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.70M

---16.03M

---11.20M

---4.94M

歸屬普通股東的淨利潤

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.21%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.70M

---16.03M

---11.20M

---4.94M

基本每股收益

35.01%0.33

151.20%0.30

252.05%0.19

239.43%0.25

541.17%0.24

146.89%0.12

-134.27%-0.12

10.35%-0.18

-125.70%-0.06

-42.49%-0.25

459.63%0.36

-106.12%-0.20

174.26%0.21

51.76%-0.18

112.16%0.06

825.41%3.23

52.55%-0.29

49.69%-0.36

33.14%-0.53

33.07%-0.44

6.07%-0.61

-51.78%-0.72

-36.02%-0.79

-34.68%-0.66

5.23%-0.65

62.45%-0.48

32.54%-0.58

0.00%-0.49

-66.66%-0.68

-285.45%-1.27

-27.18%-0.86

-52.26%-0.49

-80.84%-0.41

-223.46%-0.33

---0.68

---0.32

---0.23

---0.10

稀釋每股收益

33.29%0.30

140.77%0.27

241.19%0.17

230.17%0.23

515.68%0.23

144.74%0.11

-137.90%-0.12

10.35%-0.18

-126.33%-0.06

-42.49%-0.25

414.76%0.32

-106.21%-0.20

172.48%0.21

51.76%-0.18

111.96%0.06

814.03%3.18

52.55%-0.29

49.69%-0.36

33.14%-0.53

33.07%-0.44

6.07%-0.61

-51.78%-0.72

-36.02%-0.79

-34.68%-0.66

5.23%-0.65

62.45%-0.48

32.54%-0.58

0.00%-0.49

-66.66%-0.68

-285.45%-1.27

-27.18%-0.86

-52.26%-0.49

-80.84%-0.41

-223.46%-0.33

---0.68

---0.32

---0.23

---0.10

每股派息

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Kiniksa Pharmaceuticals International PLC 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 KNSA 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Kiniksa Pharmaceuticals International PLC 財年末的營收是多少？



Kiniksa Pharmaceuticals International PLC 2025 財年營收為 677.56M，高於上一財年的 423.24M。

Kiniksa Pharmaceuticals International PLC 最近一個季度的營收是多少？



Kiniksa Pharmaceuticals International PLC 最近一個季度的營收為 243.60M，同比增長 55.36%。

Kiniksa Pharmaceuticals International PLC 全年的淨利潤是多少？



Kiniksa Pharmaceuticals International PLC 2025 財年淨利潤為 59.01M。

Kiniksa Pharmaceuticals International PLC 上一季度的淨利潤是多少？



Kiniksa Pharmaceuticals International PLC 最近一個季度的淨利潤為 25.43M。

Kiniksa Pharmaceuticals International PLC 年度營業利潤是多少？



Kiniksa Pharmaceuticals International PLC 2025 財年的營業利潤為 77.22M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。